2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO31] Mini-Oral Session 31　Clinical Trial Facilitation Program 1（Trial in Progress）

Sat. Feb 19, 2022 8:20 AM - 9:10 AM Room 3 (Annex 2, 1F, Kyoto International Conference Center)

Chair：Tetsuya Kusumoto（Department of Gastroenterological Surgery / Clinical Research Institute Cancer Research Division），Hideo Baba（Department of Gastroenterological Surgery, Graduate School of Medical Sciences Kumamoto University）

[MO31-4] Phase 1b/2 trial of tucatinib+trastuzumab+/-chemotherapy or pembrolizumab in patients with metastatic HER2+ GI cancers

○Kohei Shitara1, Haeseong Park2, Tanios Bekaii-Saab3, Sunnie S. Kim4, Suneel Kamath5, Michael J. Pishvaian6, Christopher Chen7, David B. Zhen8, Joal Mayor9, Qianwen Tan9, John H. Strickler10 (1.National Cancer Center Hospital East, Kashiwa, Japan, 2.Washington University School of Medicine, 3.Mayo Clinic, 4.University of Colorado Cancer Center, 5.Cleveland Clinic, 6.Johns Hopkins Kimmel Cancer Center, 7.Stanford University School of Medicine, 8.University of Washington, 9.Seagen Inc, 10.Duke University Medical Center)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password